Skip to content

Clinical trials

Completed Genital Neoplasms, Female trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genital Neoplasms, Female Status: Completed Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20051
20061
20071
20091
20111
20121
20152
20163
20171
20181
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
AA Secord1
Advaxis, Inc.1
Cedars-Sinai Medical Center1
Kaiser Permanente1
M.D. Anderson Cancer Center1
Masonic Cancer Center, University of Minnesota1
Medstar Health Research Institute1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genital Neoplasms, Female19
Ovarian Neoplasms8
Uterine Neoplasms8
Endometrial Neoplasms6
Fallopian Tube Neoplasms6
Uterine Cervical Neoplasms5
Neoplasms4
Peritoneal Neoplasms4
Urogenital Neoplasms4
Neoplasms by Site3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.